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Bioassays have been used extensively to assess various toxicity endpoints of drinking water 
disinfection byproducts (DBPs), but an emphasis on single compounds prevails. In this re-
search, DBP mixtures were assessed using a cytotoxicity test with Chinese Hamster Ovary 
(CHO) cells and an Ames fluctuation test with Salmonella typhimurium TA-98 and TA-100 with 
and without S9 rat liver homogenate. Seven whole mixture DBP concentrates were formulated 
using reconstituted natural organic matter (NOM) extracts from the Upper Mississippi River us-
ing scaled disinfectant dosing protocols with free chlorine and monochloramine in the presence 
and absence of added bromide. DBPs were identified by gas chromatography-mass spectrome-
try (GC-MS) and quantified with an electron capture detector (GC-ECD). Four trihalomethanes, 
three dihaloacetonitriles, 1,1-dichloro-2-propanone, chloropicrin, nine haloacetic acids, and 
dalapon were identified and quantified. Exogenous N-nitrosodimethylamine (NDMA) was added 
to two monochloramine-derived concentrates because the NOM did not include precursors for 
this known human carcinogen that forms in chloraminated waters. Five synthetic DBP analog 
mixtures were formulated based on the profiles of the whole mixture DBP concentrates. DBP 
mixture concentrates exerted mild cytotoxicity to CHO cells, approaching or reaching the LD50 
in all seven concentrates, a result which could be only partially explained by the identified DBPs. 
In the Ames tests, no revertant wells were observed with the TA-98 bacterial strain, indicating 
the DBP-concentrates did not induce frameshift mutations in hisD3052. However, statistically 
significant increases in the number of revertant wells were observed in TA-100 in all seven DBP 
mixture concentrates, indicating base-substitution mutations in hisG46. Mutagenicity was 
greater with the DBP mixtures formulated with free chlorine and bromide, suggesting that bro-
mine-substituted DBPs were important contributors. Exogenous NDMA had a synergistic effect 
in the concentrate formulated with monochloramine and bromide in the presence of S9 only, in-




mutagenicity in TA-100 was explained by the nineteen identified DBPs and/or the associated 
interactions. Future work should focus on high resolution mass spectrometry techniques aimed 
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 1 
1 Introduction and Motivation 
In drinking water treatment, source water natural organic matter (NOM) reacts with disin-
fectants such as chlorine and chloramines to form disinfection byproducts (DBPs). Halogenated 
DBPs such as trihalomethanes (THMs) and haloacetic acids (HAAs) form in the greatest abun-
dance on a mass basis in most drinking waters and are regulated by the USEPA in finished 
drinking waters under the Stage 2 Disinfectant/DBP Rule (USEPA, 2006). Bromide and iodide 
naturally occur in some source waters and, if present, are oxidized by disinfectants and react 
with NOM form bromine- and iodine-substituted DBPs (Richardson et al., 2003; Plewa et al., 
2004). Compliance with the Stage 2 Rule has driven many drinking water utilities to switch to 
chloramines as a secondary disinfectant (Seidel et al., 2005). Chloramines are associated with 
depressed formation of THMs and HAAs but enhanced formation of nitrogeneous DBPs, includ-
ing non-halogenated species such as N-nitrosamines, of which N-nitrosodimethylamine (NDMA) 
is the most commonly detected species in drinking water systems (Russell et al., 2012). Among 
all the identifiable DBPs to date, NDMA is the only proven carcinogen in vivo (Tricker and 
Preussmann, 1991), but drinking water is estimated to contribute less than 1% of total NDMA 
exposure due to high endogenous formation in humans (Hrudey et al., 2013). DBP formation 
and speciation can vary based on the NOM quantity and character, disinfectant type and dose, 
and water quality parameters such as pH, temperature, bromide, and iodide. In the nearly 50 
years of DBP research, over 700 DBPs have been identified, formed using various disinfection 
schemes in a wide range of source waters (Richardson et al., 2007). Despite these important 
advances, the drivers of toxicity in drinking waters have yet to be identified. 
Epidemiological and studies suggest that treated drinking water leads to increased risks of 
certain cancers (Villanueva et al., 2004; Jeong et al., 2012). Toxicological studies offer weight-
of-evidence to support the conclusion that DBPs exert carcinogenicity and teratogenic effects in 
humans (Plewa et al., 2002; Plewa et al., 2004). Much of the current understanding of DBP 
 2 
toxicity stems from in vitro studies with single compounds or a small number of compounds un-
like what is present in treated drinking waters. Individual and collective toxicological DBP prop-
erties have been shown to provide the best information available on potential adverse health 
consequences resulting from exposure (Rice et al., 2009).  
There is a glaring lack of in vitro bioassay data for well-characterized drinking water DBP 
mixtures. This stems from the need to enrich DBPs formed in treated drinking waters by several 
orders of magnitude to induce a toxic response in a bioassay. Enrichment typically occurs by 
passing ca. 10 liters of treated drinking water through columns containing resins, followed by 
back-elution of the DBP-loaded resins with an organic solvent, such as methanol. The solvent 
can be volume reduced by evaporation to further enrich the DBPs and is then spiked into a 
small volume of water. The goal of this process is to generate DBP mixtures enriched by up to 
105-fold (Liviac et al., 2010). However, enrichment efficiencies are rarely reported in the litera-
ture and few studies include characterization of the DBP mixtures that are applied in subse-
quent bioassays. Rather, DBP characterization often occurs before enrichment only (Neale et 
al., 2012). This is an important limitation as DBPs with low affinities for the resins are enriched 
at lower levels or not at all. These shortcomings prevail in the vast majority of in vitro bioassays 
with DBP mixtures (Le Roux et al., 2017). An alternative approach to generate enriched DBP 
mixtures suitable for bioassays is to first concentrate the NOM from a source water prior to a 
scaled application of oxidant (e.g., free chlorine or chloramines) to maintain similitude in DBP 
speciation relative to the original water. This approach was used in the EPA’s Four Lab Study 
for in vivo bioassays (Pressman et al., 2010), but only once for in vitro testing and never with 
scaled oxidant dosing protocols. 
Cell-based bioassays targeting health-relevant biological endpoints can complement chemi-
cal analyses of drinking water quality. Previous research has evaluated bioassays that cover 
multiple toxicity pathways to benchmark water quality and assess treatment processes (Escher 
et al., 2013). Bioassays cover a wide variety of toxicity pathways such as induction of xenobiotic 
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metabolism, specific and reactive modes of toxic action, activation of adaptive stress response 
pathways and system responses. A battery of bioassays is recommended to assess water qual-
ity comprehensively with cytotoxicity, genotoxicity, and mutagenicity the most suitable for drink-
ing water DBPs (Plewa et al., 2002; Mestankova et al., 2014). 
Cytotoxicity tests are used to evaluate the impact of a chemical or mixture of chemicals on 
cell viability and ability for cellular growth. Cytotoxicity tests using mammalian cells are used to 
investigate the effect of single chemicals and chemical mixtures by measuring the cell density 
reduction in a prescribed manner. Assessing cell membrane integrity is one of the most com-
mon ways to measure cell viability and cytotoxic effects. The Chinese Hamster Ovary (CHO) 
cells are used for assessing DBP cytotoxicity because of their stability, sensitivity and high re-
sistance to contamination (Plewa et al., 2002; Wagner and Plewa, 2017). The assay is per-
formed in sterile 96-well flat-bottomed microplates containing growth media, CHO cells, a blank 
(no toxicant), and serial dilutions of the toxicant, usually spanning three to six orders of magni-
tude. The microplates are sealed and incubated for 72 hours at 37 C in a humidified atmos-
phere of 5% carbon dioxide, which corresponds to three growth cycles for the CHO cells. Fol-
lowing this incubation period, the growth medium is discarded and the CHO cells are fixed in 
methanol and stained with crystal violet with the stain adhering only to intact cell membranes 
(i.e., viable CHO cells). A microplate reader is used to measure the absorbance at 595 nm in 
each well and the percentage of viable cells is calculated relative to the blank to develop a 
dose-response curve and estimate the LD50, the lethal dose at which 50% of the population is 
killed. 
The Ames test with Salmonella typhimurium is a sensitive tool in screening for potential 
genotoxic carcinogens using mutagenicity in bacteria as an endpoint (Hengstler and Oesch, 
2001). Ames tests are a cost-effective approach to identify substances that can cause genotoxic 
damage leading to mutations. The Ames test detects mutations in a gene of a histidine-requiring 
bacterial strain that produces a histidine-independent strain (Ames et al., 1975). TA-98 and TA-
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100 are histidine-requiring tester strains with a frameshift mutation in hisD3052 and base-substi-
tution mutation in hisG46, respectively. Because a mutation restores the histidine-independent 
strain, the Ames test is classified as a reverse mutation assay. Approximately 109 bacteria are 
incubated with a known dose of the chemical or chemical mixture being assessed. The large 
number of bacteria results in a high probability that a mutation will cause a reverse mutation. As 
bacteria lack most of the enzymes required for the activation of promutagens to mammalian car-
cinogens, a metabolically-active fraction of rat liver homogenate – known as S9 – is added. A 
new version of the Ames test, referred to as Ames II has been developed as a microwell fluctua-
tion test in contrast to the more laborious plate incubation test. The Ames II or Ames fluctuation 
test is performed entirely in liquid culture and allows for high-throughput screening and requires 
less test chemical. An Ames-positive chemical is not necessarily harmful in humans and, there-
fore, often triggers additional mutagenicity tests, both in vitro and in vivo, to eliminate false-posi-
tives caused by differences in the rat and human liver function. 
The objectives of this research are to (1) investigate the cytotoxicity and mutagenicity of 
DBP mixtures formulated with either free chlorine or monochloramine with and without added 
bromide and exogenous NDMA, and (2) assess the contribution of the cytotoxicity and muta-
genicity attributable to known and identifiable DBPs. A cytotoxicity test with CHO cells and the 
Ames mutagenicity assay with TA-98 and TA-100 were used in the presence and absence of 
the S9 rat liver enzyme. DBP-mixture concentrates were formulated with reconstituted NOM ob-
tained from Upper Mississippi River dosed with free chlorine and monochloramine with and 
without added bromide using procedures developed elsewhere (Pressman et al., 2010; Press-
man et al., 2012; Do et al., 2015). The cytotoxicity and mutagenicity of these DBP-mixture con-
centrates were assessed and the DBPs identified by GC-MS and quantified by GC-ECD. Next, 
synthetic DBP-mixture analogs were formulated with the identifiable and commercially-available 
DBPs in accordance to their respective concentration profiles in the DBP-mixture concentrates 
and tested in the bioassays. The DBP-mixture concentrates and synthetic DBP-mixture analogs 
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were compared using frequentist statistical analyses (Berthouex and Brown, 2002) to identify 
toxicity relative to the controls. The findings of this study could be leveraged to improve DBP 
toxicity methodologies and help prioritize in vivo toxicity studies. 
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2 Materials and Methods 
2.1 Overview 
This chapter details the materials and methods used in the in vitro toxicity bioassays with 
disinfection byproduct (DBP) mixtures and include the formulation of the DBP mixture-concen-
trates, DBP identification and quantification, and the formulation of the synthetic DBP mixture-
analogs. Both the DBP mixture-concentrates and synthetic analogs were assessed for toxicity 
using in vitro bioassays, which included a cytotoxicity test with Chinese Hamster Ovary (CHO) 
cells and Ames mutagenicity test with two strains of Salmonella typhimurium bacteria, TA98 and 
TA100, in the presence and absence of the S9 rat liver enzyme. Tukey’s tests at the  = 0.01 
significance-level were applied to the bioassay data to compare conditions and identify toxicity 
relative to the control conditions. 
2.2 Sterile Procedures for Contamination Prevention 
Milli-Q water (18.2 MΩ-cm) generated from Millipore Integral 3 Milli-Q water system (Biller-
ica, MA) was used for all aqueous phase preparations for the in vitro toxicity bioassays. CHO 
cells and bacteria strains were grown in a CO2 incubator and a benchtop orbital shaker, respec-
tively. The CHO cells and bacteria strains were handled in a biosafety cabinet (BSL-2A) and 
checked to ensure they were contamination-free before use. Prior to each experiment, the bi-
osafety cabinet was disinfected using UV light for fifteen minutes and work surfaces wiped peri-
odically with 70% ethanol to suppress contamination to the extent possible. 
2.3 Disinfection Byproduct Mixtures 
2.3.1 Formulation of DBP Mixture Concentrates 
To induce toxicity in short-term bioassays (i.e., less than one week), DBPs must be pre-
sent at higher concentrations than in treated drinking waters, often by five to seven orders of 
magnitude (Plewa et al., 2002). The technique developed by Pressman et al. (2010) was used 
to formulate concentrated DBP mixtures with speciation profiles proportionally scaled-up from 
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the disinfection of a natural water. Here, DBP mixture-concentrates were formulated using free 
chlorine and monochloramine dosed to reconstituted natural organic matter (NOM) in the pres-
ence and absence of purposely-added bromide. Freeze-dried NOM from the Upper Mississippi 
River (UMR) was acquired from the International Humic Substances Society and reconstituted 
under acidic conditions (i.e., pH less than 3) at a target dissolved organic carbon (DOC) ca. 100 
mgL-1. Batches of concentrate were formulated by dissolving 200 mg UMR-NOM in 600 mL 
Milli-Q water and stirring continuously for five days. The NOM concentrate was adjusted to pH 7 
with NaOH and twice-filtered through 0.45 µm poly(ether)-sulfone membranes prior to measure-
ment of DOC and dilution with Milli-Q water to a DOC of ca. 100 mgL-1. The DOC was meas-
ured with a Sievers 5310C Portable TOC Analyzer (Sievers, Boulder, CO) and the UV absorb-
ance was measured in a 1 cm pathlength quartz cuvette. The specific UV absorbance (SUVA) 
was calculated by dividing the UV254 by the DOC and reported in units of Lmg-1m-1. Half of the 
reconstituted UMR-NOM concentrate (i.e., a 300 mL aliquot) was spiked with bromide at a final 
concentration of 3.96 mgL-1 to form brominated-DBPs upon chlorination or chloramination, 
which are generally considered to be more toxic (Richardson et al., 2003; Plewa et al., 2004). 
The other 300-mL aliquot was left unamended without any added bromide. Each 300-mL aliquot 
was halved again to produce a total of four, 150-mL, aliquots for dosing with either free chlorine 
or monochloramine as described next. 
The DOC in the UMR-NOM concentrates (ca. 100 mgL-1) was considered to be a fifty-
fold-enrichment (i.e., 50X) by assuming the DOC in the 1X sample was 2 mgL-1. The free chlo-
rine dose applied to the UMR-NOM concentrate was 218 mgL-1-Cl2, a dose that scaled based 
on the 24-hour free chlorine dose of the 1X sample that resulted in a residual of 1.0 mgL-1-Cl2 
(Pressman et al., 2010). A second free chlorine dose of 60 mgL-1-Cl2 was used to formulate an 
additional concentrate for comparison purposes. For the monochloramine-based DBP concen-
trate-mixtures, the monochloramine dose was 250 mgL-1-Cl2 and a hold-time of seven days, a 
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protocol that was based on previously work by Do et al. (2015). Following their respective hold-
times, the residual free chlorine or monochloramine was quenched using ascorbic acid such 
that the mixtures contained DBPs but no residual disinfectant. These samples were assessed in 
the cytotoxicity and mutagenicity bioassays as described in Sections 2.4 and 2.5. 
2.3.2 Commercially-available and Identifiable DBPs 
Table 2-1 shows the commercially-available and identifiable DBPs that formed in the 
DBP-concentrates, which include the four regulated trihalomethanes, one haloketone, one 
halonitromethane, and two dihaloacetonitriles, nine haloacetic acids, and dalapon (see Table 2-
1). The eighteen DBPs in Table 2-1 were quantified by two separate analyses, one for haloace-
tic acids and dalapon and the other for trihalomethanes, haloketones, halonitromethanes, and 
dihaloacetonitriles. 
 Previous work by this lab group has shown that the DBPs listed in Table 2-1 with the ex-
ception of the HAAs and dalapon could be quantified by a single GC analysis following a liquid-
liquid extraction into a 1:1 v/v mixture of hexane and dichloromethane. Here, a 10 mL sample of 
the DBP mixture-concentrate was fortified with 0.5 mL of 0.5 mg/L trichloroethane internal 
standard. Next, 0.5 mL hexane:dichloromethane (1:1 v/v) was added and the sample shaken for 
15 minutes on a back-and-forth shaker table at high-speed; after a 5-minute quiescent settling 
period, the organic solvent layer was decanted with a Pasteur pipette. This extraction process 
was then repeated in an attempt to achieve a more complete DBP extraction and the ca. 1 mL 
extract was put into a glass GC vial and stored for at 4 C prior to DBP analyses. DBPs in the 
mixture-concentrates were identified and quantified GC-ECD by matching the retention times of 
analytical DBP standards injected one at a time. Splitless injections of 1 µL were used with an 
injector temperature of 250 C. The separation column used was a RESTEK DB-1 with a length 
of 30 m, inner diameter 0.25 mm, and a stationary phase film thickness of 1 µm. Six-point DBP 
standard curves (1-1,000 µg/L) were used to quantify the unknowns and correlation coefficients, 
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R2 exceeded 0.99 for all compounds. Blanks and check standards were run after every ten in-
jections. DBP-standards were extracted following the same procedures as the samples. 
Table 2-1. Commercially-available and Identifiable DBPs in the Concentrate-Mixtures 




Bromodichloromethane BDCM 75-27-4 CHBrCl2 
Chlorodibromomethane CDBM 124-48-1 CHBr2Cl 
Tribromomethane TBM 75-25-2 CHBr3 









Bromochloroacetonitrile BCAN 83463-62-1 C2HBrClN 
Monochloroacetic acid MCAA Haloacetic 
acid 
79-11-8 ClCH2COOH 
Monobromoacetic acid MBAA 79-08-3 BrCH2COOH 
Dichloroacetic acid DCAA 79-43-6 Cl2CHCOOH 
Bromochloroacetic acid BCAA 5589-96-3 BrClCHCOOH 
Trichloroacetic acid TCAA 76-03-9 Cl3CCOOH 
Dibromoacetic acid DBAA 631-41-1 Br2CHCOOH 
Bromodichloroacetic acid BDCAA 7113-314-7 BrCl2CCOOH 
Chlorodibromoacetic acid CDBAA 5278-95-5 Br2ClCCOOH 
Tribromoacetic acid TBAA 75-96-7 Br3CCOOH 
2,2-dichloropropanoic acid Dalapon Herbicide 75-99-0 C3H4Cl2O2 
HAAs were quantified by EPA Method 552.2 in which compounds are alkylated with 
methanol to methyl esters prior to liquid-liquid extraction into MtBE and analysis by GC-ECD. 
DBP-standards were extracted following the same procedures as the samples. Trichloropro-
pane was used as the internal standard and bromobutanoic acid was used as the surrogate 
standard. The DBPs in the concentrate mixtures were brought to a pH lower than 2.0 by addi-
tion of concentrated sulfuric acid. Addition of anhydrous sodium sulfate and MTBE with internal 
standard allowed the target analytes to transition out of the aqueous phase and into the solvent 
phase. This transition was aided by the use of a back-and-forth shaker table at high speed for 3 
minutes. After a 2-minute settling period, the upper MTBE layer was decanted with a Pasteur 
pipette into a glass conical vial. Acidic methanol was added to the extract prior to the 2-hour 
heating period at 50 C. After the heating period, an aqueous solution of sodium sulfate was 
added to the conical vials followed by a brief vortex and 2-minute settling period. The acidic 
aqueous methanol layer was removed before neutralization with saturated sodium bicarbonate. 
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After neutralization, the upper ether layer was extracted with a Pasteur pipette into a glass GC 
vial and stored at 4 C prior to DBP analyses. DBPs were identified by gas chromatography with 
a mass-selective detector and quantified GC-ECD. Splitless injections of 1 µL were used with an 
injector temperature of 200 C. The separation column used was an Agilent DB-1 with a length 
of 30 m, inner diameter 0.25 mm, and a stationary phase thickness of 1 µm. Twelve-point HAA 
standard curves (0.01-500 µg/L) were used to quantify the unknowns and correlation coeffi-
cients, R2, exceeded 0.99 for all compounds. Blanks were run after every six injections and 
check standards were run after every nine injections. 
2.3.3 Synthetic Analog DBP Mixtures 
The commercially-available DBPs identified in mixture-concentrates (Table 2-1) were ac-
quired as single compounds from AccuStandard (New Haven, CT) and used to quantify DBPs in 
the mixture-concentrates and formulate synthetic analog mixture for testing in the CHO-cytotoxi-
city and Ames mutagenicity bioassays. A total of five synthetic mixtures were formulated based 
on the whole-mixture DBP concentrates, which included two with free chlorine (added bro-
mide/no bromide), two with monochloramine (added bromide/no bromide), and NDMA only. Us-
ing the approach, differences in cytotoxicity and/or mutagenicity between the DBP mixture-con-
centrates and synthetic DBP-analogs are attributable to identified DBPs that are not commer-
cially-available, non-identified DBPs, or interaction effects (synergistic and antagonistic) 
amongst these various groups of DBPs. 
2.4 Cytotoxicity Bioassay 
2.4.1 Test Preparation 
Chinese hamster ovary (CHO) mammalian cells were used for the in vitro cytotoxicity 
tests with cell line AS52, clone 11-4-8.39-41. The live culture of CHO cells were obtained from 
Dr. Michael Plewa at the University of Illinois Urbana-Champaign and preserved in Ham’s F-12 
Fetal Bovine Serum (FBS) and dimethyl sulfoxide (DMSO) at -80 °C. To prepare the CHO cells 
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for use in the bioassays, an aliquot was removed from the freezer and centrifuged to remove the 
FBS and DMSO prior to transferring into Ham’s F12 nutrient medium containing 5% FBS, 1% 
antibiotics (100 UnitsmL-1 sodium penicillin G, 100 μgmL-1 streptomycin sulfate, and 0.25 
μgmL-1 amphotericin B in 0.85% saline), and 1% glutamine. The CHO cells were grown to con-
fluency over three-to-four days at 37 °C in a humidified atmosphere of 5% carbon dioxide in 
Ham’s F12 medium. Confluency was approximated as 70-90% plate coverage when checked 
visually under the microscope. Before harvesting, the attached CHO cells were washed with 
Hank's Balanced Salt Solution (HBSS) twice, and detached from the petri-dishes using 1 mL of 
trypsin. Ham’s F12 medium was used to stop the reaction with trypsin and resuspend the cells. 
The cell concentration was measured using a Beckman Coulter Multisizer-4 and reported in 
number of cells per mL. This concentration was used to determine the aliquot volume required 
to achieve three-thousand cells in each microplate well as detailed next in Section 2.4.2. 
2.4.2 DBP Testing with Chinese Hamster Ovary Cells 
The in vitro cytotoxicity bioassay with CHO cells is a measure of cell density reduction 
from a DBP or DBP-mixture over an exposure time of 72 hours. In this bioassay, there is a di-
rect relationship between the absorbance of crystal violet dye and the number of attached (or 
viable) CHO cells (Plewa et al., 2002). A sterile-flat-bottom 96-well-microplate was used to test 
serial dilutions of the DBP mixtures. The first column in the microplate serves as blank (contains 
no CHO cells) consisting of 120 L Milli-Q water and 80 L F12-FBS – these wells should not 
retain any of the crystal violet staining. The second column serves as the negative control (or 
optimum growth condition), with each well containing ca. 3,000 CHO cells added in a 100 L ali-
quot, 80 L of F12-FBS medium, and 20 L Milli-Q water – these wells should retain a maxi-
mum amount of the crystal violet staining. The remaining columns contain 3,000 CHO cells 
added in a 100 L aliquot, 80 L of F12-FBS medium, and a known concentration of the toxi-
cant mixture added in a 20 L aliquot. Following dosing, each plate was sealed with a sterile 
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aluminum sheet to prevent cross and outside contamination. The plates were agitated on a 
back-and-forth shaker for five minutes to ensure even distribution of the CHO cells on the flat 
bottom of each well, and then the plate was incubated at 37 °C under a 5% CO2 atmosphere for 
72 hours. Next, the liquid within each well was disposed and 50 µL of methanol was added for 
10 minutes for cell fixation. Then the cells were stained using 1% crystal violet solution in 50% 
methanol for 10 min. The microplates were washed twice before 50 L DMSO/methanol (3/1 
v/v) was added and placed in darkness for 10 min. The microplate was analyzed at an absorb-
ance of 595 nm using a Bio-Tek microplate reader. The absorbance readings for each plate 
were collected and stored in a MS Excel spreadsheet prior to analysis as described next in Sec-
tion 2.4.3. 
2.4.3 Data Analysis 
The median absorbance of the blank wells was subtracted from all the wells to yield blank-
corrected readings. The median blank-corrected absorbance of the negative-control was set at 
100% and the absorbance for each treatment-well was calculated based on the percentage of 
the negative control. These data were used to generate a dose-response profile for each DBP 
mixture. In cases in which the LD50 was surpassed, regression analysis was applied to esti-
mate the LD50 value, which is the concentration that resulted in a cell density that was 50% of 
the negative control. The lowest concentration that induced a significant level of cytotoxicity was 
determined using a Tukey’s test at an  = 0.01 significance-level. 
2.5 Ames Mutagencity Bioassay 
2.5.1 Test Preparation 
Salmonella typhimurium bacteria strains TA98 and TA100 and S9 rat liver enzyme were 
obtained from Moltox Inc. and used for the Ames mutagenicity bioassay. The mutagenicity 
mechanism differs between these two bacteria strains: TA98 has a frameshift sensitivity and 
TA100 has a base-pair-substitution sensitivity. Four test conditions were evaluated: TA98 
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without S9 (TA98-S9), TA98 with S9 (TA98+S9), TA100 without S9 (TA100-S9), and TA100 
with S9 (TA100+S9). Both bacteria strains were inoculated on a temperature controlled shaker 
table at 150 rpm and 37 C in autoclaved Nutrient Broth #2 media (10 mgL-1 beef and yeast ex-
tracts, 10 mgL-1 peptone, 5 mgL-1 sodium chloride, adjusted to pH 7.5  0.2 with added ampicil-
lin) for approximately 12 hours before Ames tests. 
2.5.2 DBP Testing with Bacteria Strains 
The Ames fluctuation assay (ISO 11350) was used to assess the mutagenicity of the 
DBP mixture-concentrates. The abundances of TA98 and TA100 bacteria in their respective 
stock cultures were estimated by measuring the optical density with a spectrophotometer at 595 
nm; midway through the research, this measurement was replaced with a coulter counter esti-
mate taken from particle diameters between 0.7 and 1.7 microns. 
The Ames bioassay begins in sterile 24-well flat plates. Each well contained 100 L of 
the TA98 or TA100 bacteria stock culture, 100 L of exposure medium (0.81 mM magnesium 
sulfate heptahydrate, 10.41 mM citric acid, 57.4 mM dipotassium hydrogen phosphate, 16.74 
mM sodium ammonium hydrogen phosphate tetrahydrate, and 22.2 mM D-glucose), and 34 L 
of either Milli-Q water or S9 rat liver enzyme solution (3.3 µM potassium chloride, 8.0 µM mag-
nesium chloride hexahydrate, 5.0 µM D-glucose-6-phosphate, 4.0 µM nicotinamide-adenine-di-
nucleotide phosphate, 30% (v/v) S9-fraction in 100 mM sodium dihydrogen phosphate buffer at 
pH 7.4). For each Test Condition (TA98-S9, TA98+S9, TA100-S9, and TA100+S9), there are 
four variables – a negative control, a positive control, and two toxicant dosing levels designated 
as D1 for the full-strength DBP mixture-concentrate and D10 for that diluted by a factor of ten. 
For each variable, an additional 800 L (called the dosing volume) was added to the respective 
wells such that the total volume in each well is 1034 L. For the negative control, the dosing vol-
ume is 800 L of Milli-Q water; for the positive control, the dosing volume is 780 L of Milli-Q 
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water and 20 L of positive control stock solution, which includes a different agent for each Test 
Condition (see Table 2-2). 
Table 2-2. Positive control chemicals for the Ames Bioassay 
Test Condition Positive Control Agent 
Concentration in Well 
(mgL-1) 
TA98-S9 4-nitro-o-phenylenediamine (4-NOPD) 10 
TA98+S9 2-aminoanthracene (2-AA) 0.1 
TA100-S9 Nitrofurantoin (NF) 0.25 
TA100+S9 2-aminoanthracene (2-AA) 0.4 
For D1, the dosing volume is 800 L of the DBP mixture-concentrate and for D10 the dosing 
volume is 80 L of the DBP mixture-concentrate and 720 L of Milli-Q water. The negative and 
positive controls were performed in triplicate and D1 and D10 each had nine observations. 
The 24-well plates were shaken at 150 rpm at 37 °C for 100-minutes in the dark. Next, 
500 L from each well was transferred and mixed with 2.5 mL of histidine-deficient reversion-
indicator medium (magnesium sulfate heptahydrate 0.21 gL-1, citric acid monohydrate 2.1 gL-1, 
di-potassium hydrogen phosphate 10.7 gL-1, sodium ammonium hydrogen phosphate tetrahy-
drate 3.74 gL-1, D-glucose-anhydrous 4.28 gL-1, D-biotin 26 mgL-1 and 26.4 mgL-1 of the pH 
indicator dye bromocresol purple). Sample volume from each well in the 24-well-plate was 
transferred to 48-wells in a 384-well-microplate in 50 L aliquots. Each 384-well-microplate was 
placed in sterile Ziploc plastic bags in the 37 °C incubator for an exposure time of 72-hours in 
the dark without shaking. During the exposure, the histidine auxotrophic test bacteria can revert 
to the prototrophic phenotype by a mutation event. This reversion is detected by a color shift of 
the histidine-free bromocresol purple reversion indicator medium from purple to yellow, caused 
by the acidification of the medium resulting the pH to drop due to the metabolic activity of the 
revertants. Subsequently, reverent wells are yellow and non-reverent wells remain purple, each 
of which are counted and recorded. Tukey’s test at an  = 0.01 significance-level was applied to 
the number of revertant wells for each DBP mixture-concentrate and test condition (TA98 - S9, 
TA98 + S9, TA100 - S9, and TA100 + S9).  
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3 Results 
3.1 DBP Mixture Characterizations 
Table 3-1 shows the DBP profiles in the concentrate-mixtures and Table 3-2 shows the 
DBP profiles in the synthetic DBP-mixture analogs. 





(mgL-1 as Cl2) 
Monochloramine 
(mgL-1 as Cl2) 
Oxidant Dose 60 218 218 250 250 
Bromide 0 0 4 0 4 
Dissolved organic carbon 99.4 100.8 96.1 99.9 96.1 
      
Disinfection byproducts 
(gL-1) 
     
Trichloromethane (TCM) 2,213 2,311 3,404 1,195 690 
Dichlorobromomethane (DCBM) 26 45 1,643 16 1,126 
Dibromochloromethane (DBCM) ND ND 249 ND 403 
Tribromomethane (TBM) ND ND ND ND 44 
      
Dichloroacetonitrile (DCAN) 117 41 42 193 167 
Bromochloroacetonitrile (BCAN) ND ND ND ND 11 
Dibromoacetonitrile (DBAN) ND ND ND ND 5 
      
Propanone 35 35 26 35 15 
Chloropicrin ND ND ND 2 ND 
      
Monochloroacetic acid (MCAA) 93 113 117 87 74 
Monobromoacetic acid (MBAA) ND 6 26 1 29 
Dichloroacetic acid (DCAA) 522 1,910 1,737 1,167 860 
Bromochloroacetic acid (BCAA) 5 9 368 10 371 
Trichloroacetic acid (TCAA) 889 4,336 3,843 289 187 
Dibromoacetic acid (DBAA) ND ND 38 ND 88 
Bromodichloroacetic acid (BDCAA) 1 5 385 ND 29 
Chlorodibromoacetic acid (CDBAA) ND ND 49 ND 5 
Tribromoacetic acid (TBAA) 9 47 34 3 3 
      
Dalapon 19 130 117 20 10 
      
*samples dosed at pH 7 in 20 mM bicarbonate buffer following Do et al., (2015) 
ND – not detected 
The impact of NDMA was assessed by addition of this compound to an aliquot of each of mix-
ture concentrates formulated with monochloramine (Table 3-1). Therefore, a total of seven 
whole-water DBP mixture concentrates were formulated and tested in the bioassays. 
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(mgL-1 as Cl2) 
Monochloramine 
(mgL-1 as Cl2) 
Oxidant Dose  60 218 218 250 250 
Bromide  0 0 4 0 4 
Dissolved organic carbon 99.4 100.8 96.1 99.9 96.1 
      
Disinfection byproducts 
(gL-1) 
     
Trichloromethane (TCM) NF 2,400 3,600 NF 800 
Dichlorobromomethane (DCBM) NF 50 1,700 NF 1,200 
Dibromochloromethane (DBCM) NF ND 300 NF 500 
Tribromomethane (TBM) NF ND ND NF 50 
      
Dichloroacetonitrile (DCAN) NF 50 50 NF 200 
Bromochloroacetonitrile (BCAN) NF ND ND NF 25 
Dibromoacetonitrile (DBAN) NF ND ND NF 5 
      
Propanone NF 50 25 NF 25 
Chloropicrin NF ND ND NF ND 
      
Monochloroacetic acid (MCAA) NF 120 120 NF 74 
Monobromoacetic acid (MBAA) NF 8 32 NF 32 
Dichloroacetic acid (DCAA) NF 2,000 1,800 NF 900 
Bromochloroacetic acid (BCAA) NF 10 400 NF 400 
Trichloroacetic acid (TCAA) NF 5,000 4,000 NF 200 
Dibromoacetic acid (DBAA) NF ND 40 NF 88 
Bromodichloroacetic acid (BDCAA) NF 5 389 NF 32 
Chlorodibromoacetic acid (CDBAA) NF ND 52 NF 6 
Tribromoacetic acid (TBAA) NF 48 40 NF 4 
      
Dalapon NF 160 125 NF 10 
*Profiles formulated based on these conditions and values in Table 3-1 
NF – not formulated; ND – not detected 
A total of five synthetic analog mixtures were tested in the bioassays, which included the three 
in Table 3-2, NDMA alone, and exogenous NDMA added to the synthetic analog formulated 
based on the DBP profile produced with monochloramine and bromide (Table 3-2). 
3.2 Bioassays 
Results of the cytotoxicity tests with CHO cells and Ames mutagenicity tests with TA-98 
and TA100 in the presence and absence of S9 rat liver enzyme are shown in Figures 3-1 to 3-




Figure 3-1. Bioassay results for a disinfection byproduct mixture-concentrate formulated by re-
acting 60 mg/L-Cl2 free chlorine with 99.4 mg/L dissolved organic carbon for 24-hours at pH 7. 
(a) cytotoxicity bioassay with Chinese Hamster Ovary cells and (b) Ames test with TA-98 and 
TA-100 bacteria with and without S9 rat liver enzyme. Asterisk(s) indicate the number of positive 
wells is greater at the  = 0.01 significance-level than the *Negative Control only, **Dilution-10 


































Free Chlorine Dose = 60 mg/L-Cl2
Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 99.4 mg/L
Hold time of 24-hours at pH 7





























Dilution Factor of DBP-concentrate (unitless)
Whole-Mixture DBP Concentrate
Formulated with:
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Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 99.4 mg/L
Hold time of 24-hours at pH 7






Figure 3-2. Bioassay results for a disinfection byproduct mixture-concentrate formulated by re-
acting 218 mg/L-Cl2 free chlorine with 100.8 mg/L dissolved organic carbon for 24-hours at pH 
7. (a) cytotoxicity bioassay with Chinese Hamster Ovary cells and (b) Ames test with TA-98 and 
TA-100 bacteria with and without S9 rat liver enzyme. Asterisk(s) indicate the number of positive 
wells is greater at the  = 0.01 significance-level than the *Negative Control only, **Dilution-10 

































Free Chlorine Dose = 218 mg/L-Cl2
Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 100.8 mg/L
Hold time of 24-hours at pH 7
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Figure 3-3. Bioassay results for a synthetic disinfection byproduct mixture-analog with the DBP 
profile shown in Table 3-2 corresponding to the mixture formulated by reacting 218 mg/L-Cl2 
free chlorine with 100.8 mg/L dissolved organic carbon for 24-hours at pH 7. (a) cytotoxicity bio-
assay with Chinese Hamster Ovary cells and (b) Ames test with TA-98 and TA-100 bacteria with 
and without S9 rat liver enzyme. Asterisk(s) indicate the number of positive wells is greater at 
the  = 0.01 significance-level than the *Negative Control only, **Dilution-10 and Negative Con-



























*** *** ***Synthetic DBP mixture
Formulated based on:
Free Chlorine Dose = 218 mg/L-Cl2
Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 100.8 mg/L
Hold time of 24-hours at pH 7
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Hold time of 24-hours at pH 7






Figure 3-4. Bioassay results for a disinfection byproduct mixture-concentrate formulated by re-
acting 218 mg/L-Cl2 free chlorine with 96.1 mg/L dissolved organic carbon and 3.96 mg/L bro-
mide for 24-hours at pH 7. (a) cytotoxicity bioassay with Chinese Hamster Ovary cells and (b) 
Ames test with TA-98 and TA-100 bacteria with and without S9 rat liver enzyme. Asterisk(s) in-
dicate the number of positive wells is greater at the  = 0.01 significance-level than the *Nega-



































Free Chlorine Dose = 218 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of 24-hours at pH 7
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Figure 3-5. Bioassay results for a synthetic disinfection byproduct mixture-analog with the DBP 
profile shown in Table 3-2 corresponding to the mixture formulated by reacting 218 mg/L-Cl2 
free chlorine with 96.1 mg/L dissolved organic carbon and 3.96 mg/L bromide for 24-hours at pH 
7. (a) cytotoxicity bioassay with Chinese Hamster Ovary cells and (b) Ames test with TA-98 and 
TA-100 bacteria with and without S9 rat liver enzyme. Asterisk(s) indicate the number of positive 
wells is greater at the  = 0.01 significance-level than the *Negative Control only, **Dilution-10 



























*** *** ***Synthetic DBP mixture
Formulated based on:
Free Chlorine Dose = 218 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of 24-hours at pH 7
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Figure 3-6. Bioassay results for a disinfection byproduct mixture-concentrate formulated by re-
acting 250 mg/L-Cl2 monochloramine with 99.9 mg/L dissolved organic carbon for 7-days at pH 
7. (a) cytotoxicity bioassay with Chinese Hamster Ovary cells and (b) Ames test with TA-98 and 
TA-100 bacteria with and without S9 rat liver enzyme. Asterisk(s) indicate the number of positive 
wells is greater at the  = 0.01 significance-level than the *Negative Control only, **Dilution-10 

































Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 99.9 mg/L
Hold time of seven days at pH 7
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Formulated with:
Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 99.9 mg/L
Hold time of seven days at pH 7






Figure 3-7. Bioassay results for a disinfection byproduct mixture-concentrate formulated by re-
acting 250 mg/L-Cl2 monochloramine with 96.1 mg/L dissolved organic carbon and 3.96 mg/L 
bromide for 7-days at pH 7. (a) cytotoxicity bioassay with Chinese Hamster Ovary cells and (b) 
Ames test with TA-98 and TA-100 bacteria with and without S9 rat liver enzyme. Asterisk(s) in-
dicate the number of positive wells is greater at the  = 0.01 significance-level than the *Nega-


































Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of seven days at pH 7
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Figure 3-8. Bioassay results for a synthetic disinfection byproduct mixture-analog with the DBP 
profile shown in Table 3-2 corresponding to the mixture formulated by reacting 250 mg/L-Cl2 
monochloramine with 96.1 mg/L dissolved organic carbon and 3.96 mg/L bromide for 24-hours 
at pH 7. (a) cytotoxicity bioassay with Chinese Hamster Ovary cells and (b) Ames test with TA-
98 and TA-100 bacteria with and without S9 rat liver enzyme. Asterisk(s) indicate the number of 
positive wells is greater at the  = 0.01 significance-level than the *Negative Control only, **Dilu-



























*** *** ***Synthetic DBP mixture
Formulated based on:
Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of 24-hours at pH 7





























Dilution Factor of DBP-concentrate (unitless)
Synthetic DBP mixture
Formulated based on:
Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of 24-hours at pH 7






Figure 3-9. Bioassay results for N-Nitrosodimethylamine (NDMA) only. (a) cytotoxicity bioassay 
with Chinese Hamster Ovary cells and (b) Ames test with TA-98 and TA-100 bacteria with and 
without S9 rat liver enzyme. Asterisk(s) indicate the number of positive wells is greater at the  
= 0.01 significance-level than the *Negative Control only, **Dilution-10 and Negative Control, 




































































Figure 3-10. Bioassay results for a disinfection byproduct mixture-concentrate formulated by re-
acting 250 mg/L-Cl2 monochloramine with 99.9 mg/L dissolved organic carbon for 7-days at pH 
7 and amended with N-Nitrosodimethylamine (NDMA). (a) cytotoxicity bioassay with Chinese 
Hamster Ovary cells and (b) Ames test with TA-98 and TA-100 bacteria with and without S9 rat 
liver enzyme. Asterisk(s) indicate the number of positive wells is greater at the  = 0.01 signifi-
cance-level than the *Negative Control only, **Dilution-10 and Negative Control, and ***Dilution-





















D1 + 774 ng/L
NDMA










Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 99.9 mg/L
Hold time of seven days at pH 7






























Dilution Factor of DBP-concentrate (unitless)
Whole-Mixture DBP Concentrate
Formulated with:
Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 0 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 99.9 mg/L
Hold time of seven days at pH 7
Buffer = 20 mM NaHCO3






Figure 3-11. Bioassay results for a disinfection byproduct mixture-concentrate formulated by re-
acting 250 mg/L-Cl2 monochloramine with 96.1 mg/L dissolved organic carbon and 3.96 mg/L 
bromide for 7-days at pH 7 and amended with N-Nitrosodimethylamine (NDMA). (a) cytotoxicity 
bioassay with Chinese Hamster Ovary cells and (b) Ames test with TA-98 and TA-100 bacteria 
with and without S9 rat liver enzyme. Asterisk(s) indicate the number of positive wells is greater 
at the  = 0.01 significance-level than the *Negative Control only, **Dilution-10 and Negative 
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Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of seven days at pH 7































Dilution Factor of DBP-concentrate (unitless)
Whole-Mixture DBP Concentrate
Formulated with:
Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of seven days at pH 7
Buffer = 20 mM NaHCO3






Figure 3-12. Bioassay results for a synthetic disinfection byproduct mixture-analog with the DBP 
profile shown in Table 3-2 corresponding to the mixture formulated by reacting 250 mg/L-Cl2 
monochloramine with 96.1 mg/L dissolved organic carbon and 3.96 mg/L bromide for 24-hours 
at pH 7 and amended with N-Nitrosodimethylamine (NDMA). (a) cytotoxicity bioassay with Chi-
nese Hamster Ovary cells and (b) Ames test with TA-98 and TA-100 bacteria with and without 
S9 rat liver enzyme. Asterisk(s) indicate the number of positive wells is greater at the  = 0.01 
significance-level than the *Negative Control only, **Dilution-10 and Negative Control, and ***Di-
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*** *** ***Synthetic DBP mixture
Formulated based on:
Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of seven days at pH 7






























Dilution Factor of DBP-concentrate (unitless)
Synthetic DBP mixture
Formulated based on:
Monochloramine Dose = 250 mg/L-Cl2
Bromide Dose = 3.96 mg/L-Br
Upper Mississippi River NOM
DOC Dose = 96.1 mg/L
Hold time of seven days at pH 7
Buffer = 20 mM NaHCO3






4.1 Cytotoxicity Tests with CHO Cells 
At dilution factors of 10, 100, and 1,000, no cytotoxicity was exerted relative to 100% Vi-
able CHO Cells Remaining in any whole-mixture DBP-concentrates or their synthetic analogs ( 
= 0.01, Figures 3-1a to 3-12a). However, the following undiluted (e.g., dilution factor = 1) whole-
mixture DBP-concentrates exerted some cytotoxicity, with the percentage of viable CHO cells 
remaining crossing the LD50 in at least one of the eight observations: 
• 60 mgL-1 as Cl2 free chlorine dose (Figure 3-1a) 
• 218 mgL-1 as Cl2 free chlorine dose (Figure 3-2a) 
• 218 mgL-1 as Cl2 free chlorine dose with 4 mgL-1 bromide (Figure 3-4a) 
Among the full-strength dilutions, the whole-mixture DBP-concentrates formulated using free 
chlorine were not more cytotoxic than those formulated with monochloramine ( = 0.01). The 
addition of 100 ngL-1 NDMA did not increase the cytotoxicity ( = 0.01) of the whole-mixture 
DBP-concentrates formulated with monochloramine (Figures 3-6a vs. 3-10a) or monochlora-
mine with bromide (Figures 3-7a vs. 3-11a). Comparison the full-strength whole-mixture DBP-
concentrates to their synthetic analogs showed no difference in cytotoxicity ( = 0.01) in the fol-
lowing cases: 
• 218 mgL-1 as Cl2 free chlorine dose (Figure 3-2a vs. Figure 3-3a) 
• 218 mgL-1 as Cl2 free chlorine dose with 4 mgL-1 bromide (Figure 3-4a vs. Fig-
ure 3-5a) 
• 250 mgL-1 as Cl2 monochloramine dose with 4 mgL-1 bromide and 100 ngL-1 
NDMA (Figure 3-11a vs. Figure 3-12a) 
In contrast, for 250 mgL-1 as Cl2 monochloramine dose with 4 mgL-1 bromide, the synthetic an-
alog mixture was more cytotoxic ( = 0.01) than its whole mixture counterpart (Figure 3-7a vs. 
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Figure 3-8a). This result suggests mild antagonism in the whole mixture. On balance, however, 
these results indicate that the suites of commercially-available DBPs in the synthetic analog 
mixtures (see Table 3-2) could account for the observed cytotoxicity in the whole-mixture DBP-
concentrates. The specific drivers of cytotoxicity cannot be determined from these data, whether 
it stems from specific trihalomethanes, haloacetonitriles, or haloacetic acids, and/or synergistic 
interactions amongst these DBPs. Further, these data support the conclusion that there were no 
significant differences in cytotoxicity in the DBP mixtures formulated with the two disinfectant 
types (free chlorine vs. monochloramine), bromide levels (0 vs. 4 mgL-1), and for monochlora-
mine only, NDMA levels (0 vs 100 ngL-1). 
4.2 Ames Mutagenicity Tests with Salmonella typhimurium 
Ames tests were completed using TA-98 and TA-100 in the absence and presence of S9 
rat liver enzyme, including seven tests on whole-mixture DBP concentrates and five tests on 
synthetic DBP analog mixtures (Figures 3-1b through 3-12b). All tests were valid, with ten or 
less revertant wells in the negative controls and thirty to forty-eight revertant wells in the positive 
controls. For TA-98, the number of revertant wells induced by the Dilution-1 and Dilution-10 mix-
tures were not significantly greater than their corresponding negative controls ( = 0.01), indi-
cating frameshift mutations in hisD3052 were not produced by the DBP-concentrates or syn-
thetic analogs. This result is similar to that of other researchers that have used TA-98 to assess 
the mutagenicity of DBPs (Gong et al., 2005; Manasfi et al., 2017), although different DBP spe-
cies were assessed in these studies. 
For TA-100, the Dilution-10 mixtures did not produce a significant number of revertant 
wells compared to their corresponding negative controls ( = 0.01). In contrast, however, the 
Dilution-1 whole-mixture DBP-concentrates produced a significant number of revertant wells in 
TA-100 in the absence and presence of S9 in eleven out of fourteen cases (see Table 4-1). This 
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indicates a dose-response relationship and a base-substitution mutation in hisG46 (Hengstler 
and Oesch, 2001) in the following whole-mixture DBP concentrates: 
• 60 mgL-1 as Cl2 free chlorine dose (Figure 3-1b)  
o less mutagenic with S9 
• 218 mgL-1 as Cl2 free chlorine dose (Figure 3-2b) 
o less mutagenic with S9 
• 218 mgL-1 as Cl2 free chlorine dose with 4 mgL-1 bromide (Figure 3-4b) 
o more mutagenic with S9 
• 250 mgL-1 as Cl2 monochloramine dose (Figure 3-6b) 
o less mutagenic with S9 
• 250 mgL-1 as Cl2 monochloramine dose with 4 mgL-1 bromide (Figure 3-7b) 
o less mutagenic with S9 
• 250 mgL-1 as Cl2 monochloramine dose with 4 mgL-1 bromide and 774 ngL-1 NDMA 
(Figure 3-11b) 
o more mutagenic with S9 
In four out of these six cases, the whole-mixture DBP concentrates were less mutagenic with S9 
( = 0.01), in agreement with the findings of others (Bull, 1982). In the two aberrant cases in 
which the whole-mixture DBP concentrates were more mutagenic with S9 ( = 0.01), bromide 
was added prior to oxidant addition to form bromine-substituted DBPs. As shown in Table 4-1, 
the median number of revertant wells was greater in the presence of S9 in the whole-mixture 
DBP concentrates formulated with a (1) 218 mgL-1 as Cl2 free chlorine dose and 4 mgL-1 bro-
mide and (2) 250 mgL-1 as Cl2 monochloramine dose, 4 mgL-1 bromide, and 774 ngL-1 NDMA. 
The addition of S9 is intended to simulate mammalian metabolism, so this result implicates bro-
mine-substituted DBPs in driving mutagenicity in whole-mixture DBP concentrates. Table 4-1 
summarizes the median number of revertant wells in the synthetic DBP analog mixtures 
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formulated using commercially-acquired DBPs using the recipes shown in Table 3-2. In nine out 
of the ten cases, the synthetic DBP analog mixture did not induce mutagenicity in TA-100 ( = 
0.01). 














Free Chlorine 60 0 0 No 20 (3-1) NM 
Yes 14 (3-1) NM 
      
218 0 0 No 18 (3-2) 4 ns (3-3) 
Yes 12 (3-2) 3 ns (3-3) 
      
218 4 0 No 16 (3-4) 8 ns (3-5) 
Yes 27 (3-4) 9 (3-5) 
       
Monochlora-
mine 
250 0 0 No 18 (3-6) NM 
Yes 11 (3-6) NM 
      
250 4 0 No 16 (3-7) 5 ns (3-8) 
Yes 10 (3-7) 9 ns (3-8) 
      
250 0 774 No 9 ns NM 
Yes 13 ns NM 
      
250 4 774 No 10 ns (3-11) 6 ns (3-12) 
Yes 23 (3-11) 8 ns (3-12) 
       
None NA 0 774 No NA 10 ns (3-9) 
 Yes NA 8 ns (3-9) 
       
1Values without superscript ns were greater than the negative control at the  = 0.01 signifi-
cance level 
*formulated with commercially-acquired DBPs and concentrations shown in Table 3-2 
ns not significantly greater than the negative control at the  = 0.01 significance level 
NA – not applicable 
Number is parentheses (3-x) refer to the corresponding figure number 
The lone exception was the synthetic DBP analog mixture formulated based on the 218 mgL-1 
as Cl2 free chlorine dose and 4 mgL-1 bromide with a median of nine revertant wells which was 
determined to be statistically greater than the corresponding negative control (Figure 3-5). How-
ever, there were 27 revertant wells in the corresponding whole-mixture DBP concentrate (Table 
4-1 and Figure 3-4), which was the most mutagenic mixture evaluated in this research. 
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Therefore, the commercially-acquired DBPs – including four trihalomethanes, three dihaloace-
tonitriles, 1,1-dichloro-2-propanone, chloropicrin, nine haloacetic acids, and dalapon – at their 
respective concentrations similar to the whole-mixture DBP concentrates (Tables 3-1 and 3-2) 
and their associated synergistic interactions with and without exogenous NDMA do not account 
for the observed mutagenicity in TA-100. Rather, unidentified and/or unknown DBPs and their 
associated interactions with each other and/or the identified DBPs (Table 3-2) are likely driving 
the observed mutagenicity. 
NDMA at 774 ngL-1 impacts mutagenicity, as shown in Table 4-1 and by comparing Fig-
ures 3-7b, 3-9b, and 3-11b. NDMA by itself is not mutagenic (Figure 3-9b), but when NDMA is 
added to the whole-mixture DBP concentrate formulated with monochloramine and bromide 
(Figure 3-11b), TA-100 with S9 has a significant number of revertant wells. In the absence of 
NDMA addition (Figure 3-7b), both TA-100 with and without S9 have a significant number of re-
vertant wells compared to the negative control ( = 0.01). Direct comparisons of the Dilution-1 
dose for TA-100 in Figure 3-7b (monochloramine + bromide) with that in Figure 3-11b (mono-
chloramine + bromide + NDMA) indicate NDMA is an antagonistic mutagen without S9 and syn-
ergistic mutagen with S9. This observation of NDMA as an antagonistic mutagen is also true for 
the whole-mixture DBP concentrates formulated with monochloramine only (no bromide), as 
shown by comparing Figures 3-6b, 3-9b, and 3-10b. For TA-100 without S9, the whole-mixture 
DBP concentrate formulated with monochloramine only shows a statistically significant number 
of revertant wells ( = 0.01, Figure 3-6b); however, when NDMA is added, the number of re-
vertant well decreases and is no longer significantly greater than the negative control (Figures 
3-10b).  
Overall, these twelve Ames tests reveal whole-mixture DBP concentrates formulated 
with free chlorine and monochloramine induce mutagenicity in TA-100 only. The presence of 
bromide enhances mutagenicity in mammalian metabolisms in whole-mixture DBP concentrates 
 34 
formulated with free chlorine, but, for monochloramine the presence of bromide enhances muta-
genicity only when exogenous NDMA was also added. NDMA impacts mutagenicity, acting an-
tagonistically in TA-100 without S9 and synergistically with monochloramine and bromide with 
S9. The characterized DBPs – including four trihalomethanes, three dihaloacetonitriles, 1,1-di-
chloro-2-propanone, chloropicrin, nine haloacetic acids, and dalapon – and their respective in-
teractions do not account for the observed mutagenicity. Therefore, future studies should in-
clude more advanced characterizations of whole-mixture DBP concentrates in an attempt to 
characterize a greater number of DBPs, with particular attention paid to brominated species. 
This will facilitate assessment of synthetic analog mixtures with a greater number of DBP spe-
cies and hence a better chance of identifying the drivers of mutagenicity in whole-mixture con-
centrates.  
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5 Conclusions and Recommendation for Future Work 
The conclusions of this research based on the results and discussion of the DBP bioassays are: 
• The undiluted whole-mixture DBP concentrates were cytotoxic to CHO cells and ap-
proached or reached the LD50 in most cases; no statistically-significant trends were ob-
served with disinfectant type (free chlorine or monochloramine), bromide addition, or ex-
ogenous NDMA addition; similar cytotoxicity was observed in the corresponding syn-
thetic DBP analog mixtures indicating the cytotoxicity could be attributed to the commer-
cially-acquired DBPs in these mixtures, which included four trihalomethanes, three dihal-
oacetonitriles, 1,1-dichloro-2-propanone, chloropicrin, nine haloacetic acids, dalapon, 
and NDMA. 
• For TA-98, the number of revertant wells in the Dilution-1 and Dilution-10 mixtures were 
not significantly greater than their corresponding negative controls ( = 0.01), indicating 
frameshift mutations in hisD3052 were not produced by the DBP-concentrates or syn-
thetic analog mixtures. 
• For TA-100, the number of revertant wells in the Dilution-1 mixtures were significantly 
greater than their corresponding negative controls in the DBP concentrates formulated 
with free chlorine and monochloramine, indicating a base-substitution mutation in 
hisG46. 
o The presence of bromide enhances mutagenicity in mammalian metabolisms in 
whole-mixture DBP concentrates formulated with free chlorine, but, for mono-
chloramine, the presence of bromide enhances mutagenicity only when exoge-
nous NDMA was also added.  
o NDMA impacts mutagenicity, acting antagonistically in TA-100 without S9 and 
synergistically with monochloramine and bromide with S9.  
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o The characterized DBPs – including four trihalomethanes, three dihaloacetoni-
triles, 1,1-dichloro-2-propanone, chloropicrin, nine haloacetic acids, and dalapon 
– and their respective interactions do not account for the observed mutagenicity.  
• Future studies should include more advanced characterizations of whole-mixture DBP 
concentrates to reveal a greater number of DBPs, with particular attention paid to bro-
minated species. Assuming these DBPs are commercially-available, this will facilitate as-
sessment of synthetic analog mixtures with a greater number of DBP species and hence 
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